医学临床研究
   Apr. 3, 2025    Home  |  About Journal  |  Editorial Board  |  Instruction  |  Subscribe  |  Advertisement  |  Messages Board  |  Contact Us  |  中文
JOURNAL OF CLINICAL RESEARCH  2021, Vol. 38 Issue (10): 1483-1485    DOI: 10.3969/j.issn.1671-7171.2021.10.012
Original Article Current Issue | Archive | Adv Search |
Mutation and Significance of EML4-ALK Fusion Gene in NSCLC Patients
BAI Xue-mei, GUO Xuan, ZHAO Xin-han, et al
Hospital of Traditional Chinese Medicine of Yulin City, Shaanxi Province719000
Download: PDF (1264 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Abstract  【Objective】To investigate the mutation of echinoderms microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion gene in patients with non-small cell lung cancer (NSCLC) and explore its impact on the prognosis of individualized targeted therapy. 【Methods】A total of 110 NSCLC tissue specimens preserved in our hospital from February 2016 to February 2018 were selected. The mutation of EML4-ALK fusion gene was detected by real-time fluorescence quantitative PCR. The effect of the mutation on individualized targeted therapy were analyzed. 【Results】The mutation of EML4-ALK fusion gene was detected in 13 cases, the mutation rate was 11.82% (13/110). Of which, the mutation rates of EML4-ALK fusion gene were 19.23% and 23.81% in patients aged < 60 years and TNM stage Ⅲ,respectively, which were significantly higher than those in patients aged ≥ 60 years and stage Ⅰ-Ⅱ(P<0.05); The median survival time of EML4-ALK fusion gene mutation and non-mutation patients was 14.00 months (95%CI:11.71-16.29) and 13.00 months (95%CI:12.39-13.61), there was no significant difference (P> 0.05). 【Conclusion】The mutation of EML4-ALK fusion gene in NSCLC patients is related to patient's age and TNM stage, while it has no significant effect on the prognosis of individualized targeted therapy.
Key wordsCarcinoma, Non-Small-Cell Lung      Antineoplastic Agents      Genes      Prognosis     
Received: 20 July 2020     
PACS:  R734.2  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
BAI Xue-mei
GUO Xuan
ZHAO Xin-han
et al
Cite this article:   
BAI Xue-mei,GUO Xuan,ZHAO Xin-han, et al. Mutation and Significance of EML4-ALK Fusion Gene in NSCLC Patients[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(10): 1483-1485.
URL:  
http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.10.012     OR     http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I10/1483
Copyright © Editorial Board of JOURNAL OF CLINICAL RESEARCH
Supported by:Beijing Magtech